Suzhou Fengbei Biotech Stock Co., Ltd. (SHA:603334)
China · Delayed Price · Currency is CNY 49.89
+0.48 (0.97%)
Jan 23, 2026, 3:00 PM CST
SHA:603334 Market Cap
SHA:603334 has a market cap or net worth of 7.16 billion as of January 22, 2026.
Market Cap
7.16B
Enterprise Value
7.43B
Revenue
2.81B
Ranking
n/a
PE Ratio
34.93
Stock Price
49.89
Market Cap Chart
Since November 5, 2025, SHA:603334's market cap has decreased from 9.58B to 7.16B, a decrease of -25.27%. That is a compound annual growth rate of -74.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 7.09B | 18.21% |
| Dec 31, 2025 | 6.00B | -37.39% |
| Nov 5, 2025 | 9.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Ausun Pharmaceutical | 8.18B |
| Wuhan Keqian Biology Co.,Ltd | 7.68B |
| Jiangsu Aidea Pharmaceutical Group | 7.65B |
| GemPharmatech | 7.54B |
| Beijing Konruns Pharmaceutical | 6.94B |
| Xiangxue Pharmaceutical | 6.67B |
| Kexing Biopharm | 6.66B |
| Jiangsu Bioperfectus Technologies | 6.66B |